Figure legends
Figure 1. Patients with VKC in the active phase (group A) showed significant decrease of tear sCD14 and conjunctival CD14 expression when compared with healthy subjects and with patients with VKC in the quiescent phase (group Q) and after VKC recovery (group R). * = statistical significant vs healthy group; § = statistical significant vs VKC in the quiescent phase (group Q); Ç = statistical significant vs VKC recovery (group R).
Figure 2 Changes of expression of conjunctival TLR-4 and TLR-9 in patients with VKC in the active (A) and quiescent (Q) phases of the disease and after VKC recovery (R) compared with healthy controls. * = statistical significant vs healthy group; § = statistical significant vs VKC in the quiescent phase (group Q); Ç = statistical significant vs VKC recovery (group R).
Figure 3 Changes of expression of tear sCD14 and conjunctival CD14, TLR-4 and TLR-9 in patients with VKC in the active phase, 7 days after topical treatment with Hydrocortisone eye drops. * = statistical significant vs baseline.